Epstein Becker Green health care and life science lawyers regularly represent clients in a variety of debt and equity financing transactions. At EBG, our clients' business goals in a financing transaction drive the services provided, and ensure that we are responsive to client needs. In addition, Epstein Becker Green's team approach allows it to assemble the appropriate team of lawyers for any financing transaction, whether it is a multi-billion dollar private equity investment or a high-yield mezzanine loan financing.
As one of the prominent health care law firms in the country, EBG lawyers not only act as transaction counsel to clients in the health care industry in financing transactions, but also provide guidance to investors with respect to the legal landscape of sectors of the health industry, and conduct due diligence of health care-related companies. EBG lawyers have provided such services with respect to some of the largest health industry transactions over the past few years.
The health industry has not been immune to corporate scandals, and Epstein Becker Green lawyers have been deeply involved in industry efforts to adapt to the new environment in which boards operate. EBG lawyers have developed public guidance with the Office of the Inspector General for the health industry and regularly speak and publish articles regarding corporate governance.
Because of our extensive experience in the area of corporate governance in the health industry, Epstein Becker Green lawyers regularly assist for-profit and non-profit organizations develop effective governance and compliance policies and conduct audits of existing policies. In addition, EBG lawyers regularly assist boards evaluate their fiduciary obligations with respect to potential transactions, and provide guidance as to current "best practices."